Next Article in Journal
Inhibitory Effects of Constituents from Euphorbia lunulata on Differentiation of 3T3-L1 Cells and Nitric Oxide Production in RAW264.7 Cells
Previous Article in Journal
Helichrysum gymnocephalum Essential Oil: Chemical Composition and Cytotoxic, Antimalarial and Antioxidant Activities, Attribution of the Activity Origin by Correlations
Article Menu

Article Versions

Export Article

Open AccessArticle
Molecules 2011, 16(10), 8292-8304; doi:10.3390/molecules16108292

Antihyperlipidemic Properties of Novel N-(Benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-Induced Hyperlipidemic Rats

1
Faculty of Pharmacy, University of Jordan, Amman-11942, Jordan
2
Faculty of Pharmacy, Al-Zaytoonah Private University, Amman-11733, Jordan
*
Author to whom correspondence should be addressed.
Received: 19 July 2011 / Revised: 5 September 2011 / Accepted: 22 September 2011 / Published: 29 September 2011
(This article belongs to the Section Medicinal Chemistry)
Download PDF [393 KB, uploaded 18 June 2014]   |  

Abstract

In the search for new potential antihyperlipidemic agents, the present study focuses on the synthesis of novel N-(benzoylphenyl)-5-substituted-1H-indole-2-carboxamides (compounds 8-12, 15, 16, 18) and investigating their antihyperlipidemic activity using Triton WR-1339-induced hyperlipidemic rats as an experimental model. Hyperlipidemia was developed by intraperitoneal injection of Triton WR-1339 (250 mg/kg body weight). The tested animals were divided into normal control (NCG), hyperlipidemic (HG), compound 8, 9, 15, 16, 18- and bezafibrate treated groups. At a dose of 15 mg/kg body weight, compounds 9, 16, 18 and bezafibrate (100 mg/kg) significantly (p < 0.0001) reduced elevated plasma triglycerides levels after 12 h compared to the hyperlipidemic control group. However, only the group treated with compounds 9, 16 and 18 showed an obviously significant (p < 0.001) reduction in plasma total cholesterol levels after 12 h compared to the hyperlipidemic control group. Moreover, high density lipoprotein-cholesterol levels were significantly (p < 0.0001) increased in all treated groups after 12 h compared to the hyperlipidemic control group, except for compounds 8 and 15 which revealed inactive. It is therefore reasonable to assume that compounds 9, 16 and 18 may have potential in the treatment of hyperlipidemia.
Keywords: Triton WR-1339-induced hyperlipidemic rats; N-(benzoylphenyl)-5-methoxy-1H-indole-2-carboxamide; N-(Benzoylphenyl)-5-chloro-1H-indole-2-carboxamide; hypo-lipidemic activity Triton WR-1339-induced hyperlipidemic rats; N-(benzoylphenyl)-5-methoxy-1H-indole-2-carboxamide; N-(Benzoylphenyl)-5-chloro-1H-indole-2-carboxamide; hypo-lipidemic activity
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Al-Hiari, Y.; Shattat, G.; Al-Qirim, T.; El-Huneidi, W.; Sheikha, G.A.; Hikmat, S. Antihyperlipidemic Properties of Novel N-(Benzoylphenyl)-5-substituted-1H-indole-2-carboxamides in Triton WR-1339-Induced Hyperlipidemic Rats. Molecules 2011, 16, 8292-8304.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top